180 related articles for article (PubMed ID: 11326651)
1. Altered prostate specific antigen reference range after transurethral resection of the prostate.
Wolff JM; Boekels O; Borchers H; Jakse G; Rohde D
Anticancer Res; 2000; 20(6D):4977-80. PubMed ID: 11326651
[TBL] [Abstract][Full Text] [Related]
2. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
[TBL] [Abstract][Full Text] [Related]
3. Reference range of prostate-specific antigen after transurethral resection of the prostate.
Aus G; Bergdahl S; Frösing R; Lodding P; Pileblad E; Hugosson J
Urology; 1996 Apr; 47(4):529-31. PubMed ID: 8638362
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level.
van Renterghem K; Van Koeveringe G; Achten R; Van Kerrebroeck P
Eur Urol; 2007 Sep; 52(3):819-26. PubMed ID: 17418482
[TBL] [Abstract][Full Text] [Related]
5. Does transurethral resection of prostate (TURP) affect outcome in patients who subsequently develop prostate cancer?
D'Ambrosio DJ; Ruth K; Horwitz EM; Chen DY; Pollack A; Buyyounouski MK
Urology; 2008 May; 71(5):938-41. PubMed ID: 18279939
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of serum total and free prostate-specific antigen (PSA) after extended multisite prostate biopsy: Comparison among biopsy, transurethral resection of the prostate (TURP), and biopsy plus TURP.
Hara N; Koike H; Nobushita T; Miyajima N; Kawaguchi M; Nishiyama T; Takahashi K; Hohenfellner R
Urol Oncol; 2010; 28(4):355-9. PubMed ID: 19110451
[TBL] [Abstract][Full Text] [Related]
7. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical outcome of diagnostic transurethral resection of the prostate in patients with elevated prostate-specific antigen level and minor lower urinary tract symptoms.
van Renterghem K; van Koeveringe G; Achten R; van Kerrebroeck P
Urol Int; 2009; 83(1):60-5. PubMed ID: 19641361
[TBL] [Abstract][Full Text] [Related]
9. Are age-specific reference ranges for prostate specific antigen population specific?
Wolff JM; Brehmer B; Borchers H; Rohde D; Jakse G
Anticancer Res; 2000; 20(6D):4981-3. PubMed ID: 11326652
[TBL] [Abstract][Full Text] [Related]
10. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.
Aydin H; Zhang J; Samaratunga H; Tan N; Magi-Galluzzi C; Klein E; Jones JS; Zhou M
BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071
[TBL] [Abstract][Full Text] [Related]
11. Changes in serum prostate-specific antigen level after prostatectomy in patients with benign prostatic hyperplasia.
Hosseini SY; Salimi M; Hosseini Moghaddam SM
Urol J; 2005; 2(4):183-8. PubMed ID: 17602426
[TBL] [Abstract][Full Text] [Related]
12. Importance of TURP in diagnosing prostate cancer in men with multiple negative biopsies.
Philip J; Dutta Roy S; Scally J; Foster CS; Javlé P
Prostate; 2005 Jul; 64(2):200-2. PubMed ID: 15712218
[TBL] [Abstract][Full Text] [Related]
13. [Changes in prostate specific antigen levels during intravesical instillations with Calmette-Guerin bacillus: relationship with transurethral resection of the prostate].
López Llauradó H; Palou Redorta J; Montañés Bermúdez R; Samper AO; Bayarri JS; Villavicencio Mavrich H
Arch Esp Urol; 2003; 56(1):19-22. PubMed ID: 12701476
[TBL] [Abstract][Full Text] [Related]
14. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era.
Jones JS; Follis HW; Johnson JR
Prostate Cancer Prostatic Dis; 2009; 12(1):57-60. PubMed ID: 18379587
[TBL] [Abstract][Full Text] [Related]
15. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
16. Serum prostate specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasia.
Marks LS; Dorey FJ; Rhodes T; Shery ED; Rittenhouse H; Partin AW; deKernion JB
J Urol; 1996 Sep; 156(3):1035-9. PubMed ID: 8709302
[TBL] [Abstract][Full Text] [Related]
17. Incidence and factors predicting the detection of prostate cancer after transurethral resection of the prostate for clinically benign disease.
Bright EA; Manuel C; Goddard JC; Khan MA
Urol Int; 2009; 83(2):171-4. PubMed ID: 19752612
[TBL] [Abstract][Full Text] [Related]
18. Open radical retropubic prostatectomy gives favourable surgical and functional outcomes after transurethral resection of the prostate.
Palisaar JR; Wenske S; Sommerer F; Hinkel A; Noldus J
BJU Int; 2009 Sep; 104(5):611-5. PubMed ID: 19298408
[TBL] [Abstract][Full Text] [Related]
19. Prostate specific antigen measurements after minimally invasive surgery of the prostate in men with benign prostatic hypertrophy.
Shingleton WB; Terrell F; Kolski J; May W; Renfroe DL; Fowler JE
Prostate Cancer Prostatic Dis; 2000 Nov; 3(3):200-202. PubMed ID: 12497098
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of the role of transurethral resection of the prostate in patients with an elevated prostate-specific antigen level, minor lower urinary tract symptoms, and proven bladder outlet obstruction.
van Renterghem K; Van Koeveringe G; Achten R; van Kerrebroeck P
Eur Urol; 2008 Dec; 54(6):1385-92. PubMed ID: 18599187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
